Archive for October, 2006
Cell Genesys president and COO quits
Cell Genesys Inc. said Tuesday that Joseph Vallner, its president and chief operating officer, quit to take the top job at another company.
BioMarin treatment approved for sale in Japan
Japanese regulators approved the marketing of BioMarin Pharmaceutical Inc.'s Aldurazyme treatment for an enzyme deficiency in that country.
CV Therapeutics post Q3 loss despite higher revenue
CV Therapeutics Inc. on Tuesday reported a third-quarter loss of $62.7 million, or $1.23 a share, compared to a loss of $55.9 million, or $1.26 a share in the same period last year.
FTC clears Watson to buy Andrx
Watson Pharmaceuticals said federal regulators have approved its purchase of Andrx Corp. The drug company said it expects the deal to close by Friday.
Money Mailer enters Houston through franchise
Money Mailer has entered the Houston market.